Cobalt Capital Management Inc. Purchases Shares of 30,000 Cigna Group $CI

Cobalt Capital Management Inc. purchased a new stake in shares of Cigna Group (NYSE:CI) in the fourth quarter, HoldingsChannel reports. The firm purchased 30,000 shares of the health services provider’s stock, valued at approximately $8,257,000. Cigna Group comprises about 3.7% of Cobalt Capital Management Inc.’s investment portfolio, making the stock its 10th largest holding.

A number of other institutional investors have also made changes to their positions in CI. Brighton Jones LLC increased its position in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after acquiring an additional 318 shares during the last quarter. Sivia Capital Partners LLC grew its holdings in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after purchasing an additional 109 shares in the last quarter. NewEdge Advisors LLC grew its holdings in shares of Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after purchasing an additional 958 shares in the last quarter. Treasurer of the State of North Carolina grew its holdings in shares of Cigna Group by 16.6% in the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after purchasing an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. acquired a new position in shares of Cigna Group in the second quarter valued at approximately $163,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Royal Bank Of Canada lifted their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. UBS Group lifted their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Jefferies Financial Group dropped their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a report on Monday, April 20th. Barclays cut shares of Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Finally, Morgan Stanley lifted their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $338.30.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by insiders.

Cigna Group Stock Performance

Shares of CI opened at $285.27 on Thursday. The stock has a 50 day moving average price of $283.63 and a 200 day moving average price of $278.31. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $75.46 billion, a price-to-earnings ratio of 12.09, a price-to-earnings-growth ratio of 1.13 and a beta of 0.28. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.